<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Digoxin and 30-Day All-Cause Readmission in Long-Term Care Residents Hospitalized for Heart Failure</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2018-09-01">2018 September 01.</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Helen</forename><forename type="middle">M</forename><surname>Sheriff</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution">Veterans Affairs Medical Center</orgName>
								<address>
									<settlement>Washington</settlement>
									<region>DC</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>BS</roleName><forename type="first">Manik</forename><forename type="middle">R</forename><surname>Thogaripally</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution">University of Alabama at Birmingham</orgName>
								<address>
									<settlement>Birmingham</settlement>
									<region>AL</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Gurusher</forename><surname>Panjrath</surname></persName>
							<affiliation key="aff2">
								<orgName type="institution">George Washington University</orgName>
								<address>
									<settlement>Washington</settlement>
									<region>DC</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Cherinne</forename><surname>Arundel</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution">Veterans Affairs Medical Center</orgName>
								<address>
									<settlement>Washington</settlement>
									<region>DC</region>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">George Washington University</orgName>
								<address>
									<settlement>Washington</settlement>
									<region>DC</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Qing</forename><surname>Zeng</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution">Veterans Affairs Medical Center</orgName>
								<address>
									<settlement>Washington</settlement>
									<region>DC</region>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">George Washington University</orgName>
								<address>
									<settlement>Washington</settlement>
									<region>DC</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Gregg</forename><forename type="middle">C</forename><surname>Fonarow</surname></persName>
							<affiliation key="aff3">
								<orgName type="institution">University of California</orgName>
								<address>
									<settlement>Los Angeles</settlement>
									<region>CA</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Javed</forename><surname>Butler</surname></persName>
							<affiliation key="aff4">
								<orgName type="institution">State University of New York</orgName>
								<address>
									<settlement>Stony Brook</settlement>
									<region>NY</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Ross</forename><forename type="middle">D</forename><surname>Fletcher</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution">Veterans Affairs Medical Center</orgName>
								<address>
									<settlement>Washington</settlement>
									<region>DC</region>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="institution">Georgetown University</orgName>
								<address>
									<settlement>Washington</settlement>
									<region>DC</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Charity</forename><surname>Morgan</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution">University of Alabama at Birmingham</orgName>
								<address>
									<settlement>Birmingham</settlement>
									<region>AL</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Marc</forename><forename type="middle">R</forename><surname>Blackman</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution">Veterans Affairs Medical Center</orgName>
								<address>
									<settlement>Washington</settlement>
									<region>DC</region>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">George Washington University</orgName>
								<address>
									<settlement>Washington</settlement>
									<region>DC</region>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="institution">Georgetown University</orgName>
								<address>
									<settlement>Washington</settlement>
									<region>DC</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Prakash</forename><surname>Deedwania</surname></persName>
							<affiliation key="aff6">
								<orgName type="institution">University of California</orgName>
								<address>
									<addrLine>San Francisco</addrLine>
									<settlement>Fresno</settlement>
									<region>CA</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Thomas</forename><forename type="middle">E</forename><surname>Love</surname></persName>
							<affiliation key="aff7">
								<orgName type="institution">Case Western Reserve University</orgName>
								<address>
									<settlement>Cleveland</settlement>
									<region>OH</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Wilbert</forename><forename type="middle">S</forename><surname>Aronow</surname></persName>
							<affiliation key="aff8">
								<orgName type="department">Westchester Medical Center</orgName>
								<orgName type="institution">New York Medical College</orgName>
								<address>
									<settlement>Valhalla</settlement>
									<region>NY</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD, PhD</roleName><forename type="first">Stefan</forename><forename type="middle">D</forename><surname>Anker</surname></persName>
							<affiliation key="aff9">
								<orgName type="department">Department of Cardiology and Pneumology</orgName>
								<orgName type="institution">University Medicine Göttingen (UMG)</orgName>
								<address>
									<settlement>Göttingen</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff11">
								<orgName type="department" key="dep1">Division of Cardiology and Metabolism -Heart Failure</orgName>
								<orgName type="department" key="dep2">Department of Cardiology (CVK)</orgName>
								<orgName type="department" key="dep3">Berlin-Brandenburg Center for Regenerative Therapies (BCRT)</orgName>
								<orgName type="institution" key="instit1">Cachexia &amp; Sarcopenia</orgName>
								<orgName type="institution" key="instit2">Charité University Medicine</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Richard</forename><forename type="middle">M</forename><surname>Allman</surname></persName>
							<affiliation key="aff12">
								<orgName type="department" key="dep1">Department of Veterans Affairs</orgName>
								<orgName type="department" key="dep2">Geriatrics and Extended Care Services</orgName>
								<address>
									<settlement>Washington</settlement>
									<region>DC</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD, MPH</roleName><forename type="first">Ali</forename><surname>Ahmed</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution">Veterans Affairs Medical Center</orgName>
								<address>
									<settlement>Washington</settlement>
									<region>DC</region>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">University of Alabama at Birmingham</orgName>
								<address>
									<settlement>Birmingham</settlement>
									<region>AL</region>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">George Washington University</orgName>
								<address>
									<settlement>Washington</settlement>
									<region>DC</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff10">
								<orgName type="department">DZHK (German Center for Cardiovascular Research</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff13">
								<orgName type="department">Center for Health and Aging</orgName>
								<orgName type="institution">Washington DC VA Medical Center</orgName>
								<address>
									<addrLine>50 Irving St. NW</addrLine>
									<postCode>20422</postCode>
									<settlement>Washington</settlement>
									<region>DC</region>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Digoxin and 30-Day All-Cause Readmission in Long-Term Care Residents Hospitalized for Heart Failure</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2018-09-01">2018 September 01.</date>
						</imprint>
					</monogr>
					<idno type="MD5">2F63960A31AFD0D43AED27185E7316BC</idno>
					<idno type="DOI">10.1016/j.jamda.2017.03.016</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:40+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Digoxin</term>
					<term>nursing home</term>
					<term>heart failure</term>
					<term>hospital readmission</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Background-Digoxin has been shown to be associated with a lower risk of 30-day all-cause hospital readmissions in older patients with heart failure (HF).</s><s>In the current study, we examined this association among long-term care (LTC) residents hospitalized for HF.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>discharge use of digoxin were centrally collected by trained chart abstractors. <ref type="bibr" target="#b6">7</ref></s><s>Given the small number of patients admitted from the LTC, we did not assemble an inception cohort of new-users of digoxin by excluding patients who were receiving digoxin before hospital admission. <ref type="bibr" target="#b2">3</ref></s><s>Because of our aim to determine if the prior findings of the clinical effectiveness of digoxin in lowering 30-day all-cause readmission can be confirmed in patients admitted from the LTC settings and their small sample size, <ref type="bibr" target="#b2">3</ref> we included all HF patients regardless of their ejection fraction (EF), with a plan to conduct subgroup analysis and check for effect modification.</s><s>Extensive data were abstracted on demographics, various baseline characteristics including past medical history and pre-admission medication use, in-hospital care, and discharge medication.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Outcomes</head><p><s>The primary outcome of the current analysis is 30-day all-cause readmissions from the day of hospital discharge.</s><s>Data on hospitalization and time to hospitalization were obtained from the CMS Medicare Provider Analysis and Review (MedPAR) file that also contains data on services provided to Medicare beneficiaries from the time of admission to inpatient hospitals through discharge.</s><s>Our secondary outcomes included 30-day HF readmission and all-cause mortality, as well as 1-year postdischarge outcomes.</s><s>Considering the very high risk of death in hospitalized HF patients admitted from the LTC settings, to account for the competing risk of death on readmission, we also estimated composite end points of all-cause readmissions or all-cause mortality.</s><s><ref type="bibr" target="#b8">[9]</ref> Assembly of a balanced cohort: Propensity score matching Because digoxin is often prescribed for sicker patients who may have poorer outcomes, to minimize bias associated with indication of digoxin prescription, we used propensity scores or the conditional probability for the receipt of a digoxin prescription prior to discharge to assemble a matched cohort of patients in which those receiving and not receiving digoxin would be well balanced on key measured baseline characteristics. <ref type="bibr" target="#b9">10,</ref><ref type="bibr" target="#b10">11</ref></s><s>3]<ref type="bibr" target="#b13">[14]</ref> Using a greedy matching protocol described elsewhere, <ref type="bibr" target="#b14">15</ref> we assembled a matched cohort of 158 pairs of patients receiving and not receiving digoxin.</s><s>To estimate if the 29 baseline characteristics used in the propensity score model were sufficiently balanced between the two groups, we estimated absolute standardized differences for all those variables. <ref type="bibr" target="#b15">16</ref></s><s>An absolute standardized difference of 0% indicates no residual bias and differences &lt;10% are considered inconsequential.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analysis</head><p><s>Descriptive analyses comparing between-group baseline characteristics were conducted using Pearson's Chi-square and Wilcoxon rank-sum tests as appropriate.</s><s>To examine the association of digoxin use with 30-day all-cause readmission, we used Kaplan-Meier and Cox regression analyses, censoring all patients without an event at 30 days.</s><s>A significant association of digoxin use with the primary outcome of 30-day all-cause readmission among matched patients will be tested using a formal sensitivity analysis to quantify the degree of a hidden bias for an unmeasured confounder. <ref type="bibr" target="#b16">17</ref></s><s>All other associations were examined using similar Cox models.</s><s>We also examined the association of digoxin with 30-day outcomes in the pre-match cohort using a multivariable-adjusted model using all 29 baseline characteristics and the propensity scores.</s><s>All statistical tests were two-tailed with a p-value &lt;0.05 considered significant.</s><s>SPSS for Windows version 21 (IBM Corp., Armonk, NY) used for data analyses.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Baseline characteristics</head><p><s>Matched patients (n=316) had a mean age of 83 (±8) years, 74% were women and 18% were African American.</s><s>Before matching, patients receiving digoxin were more likely to have low EF, prior history of HF, atrial fibrillation, and dementia.</s><s>They were also more likely to receive diuretics and angiotensin-converting enzyme (ACE) inhibitors.</s><s>These and other imbalances were balanced after matching (Table <ref type="table" target="#tab_0">1</ref> and Figure <ref type="figure" target="#fig_0">1</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>30-day all-cause readmission</head><p><s>30-day all-cause hospital readmission occurred in 21% (33/158) and 20% (32/158) of matched patients receiving and not receiving a discharge digoxin prescription, respectively (hazard ratio {HR} when digoxin use was compared with its non-use, 1.02; 95% confidence interval {CI}, 0.63-1.66;</s><s>p=0.935;</s><s>Table <ref type="table">2</ref>).</s><s>Among the subset of 79 matched patients with EF &lt;45%, 30-day all-cause readmission occurred in 30% and 13% of those receiving and not receiving digoxin, respectively (HR, 2.54; 95% CI, 0.89-7.21;</s><s>P=0.080).</s><s>Among the subset of 96 matched patients with atrial fibrillation, 30-day all-cause readmission occurred in 20% of patients in each of the digoxin and non-digoxin groups, respectively (HR, 1.04; 95% CI, 0.42-2.55;</s><s>P=0.938).</s><s>Among the subset of 220 matched patients with normal sinus rhythm, 30-day all-cause readmission occurred in 21% of patients in each of the digoxin and non-digoxin groups, respectively (HR, 1.00; 95% CI, 0.56-1.79;</s><s>P=0.991).</s></p><p><s>Among the 545 pre-match patients, multivariable-adjusted and propensity score adjusted HRs (95% CIs) associated with digoxin prescription for 30-day all-cause readmission were 1.22 (0.80-1.84; p=0.356) and 1.20 (0.79-1.82; p=0.383), respectively.</s><s>Among the subset of 122 pre-match patients with EF &lt;45%, HR for 30-day all-cause readmission associated with digoxin use was 6.51 (95% CI, 1.67-25.31;</s><s>P=0.007).</s></p><p><s>Other 30-day outcomes 30-day all-cause mortality occurred in 11% (18/158) and 13% (20/158) of patients receiving and not receiving digoxin, respectively (HR, 0.90; 95% CI, 0.48-1.70;</s><s>p=0.742).</s><s>Consequently, digoxin use had no association with the combined end point of all-cause mortality or all-cause readmission during 30 days post-discharge (HR, 0.97; 95% CI, 0.65-1.45;</s><s>p=0.876;</s><s>Table <ref type="table">2</ref> and Figure <ref type="figure" target="#fig_1">2</ref>).</s><s>Digoxin use had no association with HF readmission.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>12-month outcomes</head><p><s>Digoxin use had no association with all-cause or HF readmission, all-cause mortality, or the combined end point of all-cause mortality or all-cause readmission during 1 year postdischarge (Table <ref type="table">3</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>Findings from our current analyses demonstrate that there is no evidence that a discharge prescription of digoxin is associated with a lower risk of 30-day all-cause readmission among older LTC residents hospitalized for decompensated HF.</s><s>Digoxin use also had no association with 30-day all-cause mortality or HF readmission.</s><s>We also observed that all associations remained non-significant for 1-year outcomes.</s><s>These associations based on a balanced propensity-matched cohort are consistent with risk-adjusted findings from the larger pre-match cohort, and suggest that digoxin, a drug known for its beneficial effect and effectiveness on hospital admission and readmission in both randomized controlled trials and in the real-world settings, had no such association with readmission in real-world LTC residents with HF.</s></p><p><s>The lack of an association of digoxin use with outcomes in HF patients admitted from the LTC facility is somewhat intriguing.</s><s>Although LTC residents with HF would be expected to avoid symptoms by restricting their mobility, their 30-day readmission rate was very similar to the one observed for older HF patients in general. <ref type="bibr" target="#b17">18</ref></s><s>Digoxin is known for its beneficial effects in high risk subset of HF patients. <ref type="bibr" target="#b18">19</ref></s><s>And, yet we found no beneficial association of digoxin with readmission in nursing home residents.</s><s>There are several potential explanations for this lack of association.</s><s>]<ref type="bibr" target="#b21">[22]</ref> Digoxin is also known for its greater efficacy in patients with HF and reduced EF. <ref type="bibr" target="#b2">3,</ref><ref type="bibr" target="#b3">4</ref></s><s>Only about a quarter of the matched patients in our study had low EF.</s><s>However, we found a trend toward higher risk for 30-day all-cause readmission when we repeated our analysis in the subset of prematch patients with low EF.</s><s>A higher comorbidity burden in older LTC residents with HF and the competing risks associated with these comorbidities may have cancelled any potential readmission benefit of digoxin use. <ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b23">24</ref></s><s>Nearly half of the older Medicare beneficiaries with HF have 5 or more other chronic morbidities, <ref type="bibr" target="#b24">25</ref> and these numbers would be expected to be higher in the LTC setting.</s><s>This is especially important as less than half of all readmissions were due to HF.</s><s>Finally, our study may be underpowered to detect an association of digoxin use with outcomes.</s><s>However, when patients were followed up for 12 months post-discharge, nearly 60% were readmitted and over 80% experienced one of the combined end point events of readmission or death due to any cause, there was no association of digoxin with any 12-month outcomes.</s></p><p><s>Findings of our study are important.</s><s>Digoxin is an inexpensive drug known for its efficacy and effectiveness in lowering readmission rates in patients with HF the reduction of which is a focus of the Affordable Care Act. <ref type="bibr" target="#b0">1,</ref><ref type="bibr" target="#b1">2,</ref><ref type="bibr" target="#b3">4,</ref><ref type="bibr" target="#b17">18</ref></s><s>Because HF is common in the LTC setting, clinicians might be tempted to prescribe digoxin to their HF patients to reduce the risk of hospital readmission.</s><s>However, finding from our study suggest that there is no evidence of a beneficial association of digoxin with readmission in the patients.</s><s>Clinicians should use caution about the routine use of digoxin and may consider other approaches such as better transitions of care and judicious use of diuretics. <ref type="bibr" target="#b25">26,</ref><ref type="bibr" target="#b26">27</ref></s><s>r study is limited by its small sample size and the observational design.</s><s>Bias due to residual confounding from a measured covariate or confounding from a hidden covariate is possible.</s><s>Because of the null association observed in our study, we were not able to perform a formal sensitivity analysis.</s><s>We also had no data on post-discharge adherence and regression dilution from crossover of treatment during follow-up may also explain the null associations. <ref type="bibr" target="#b27">28</ref></s><s>.</s><s>Finally, our study in based on fee-for-service Medicare beneficiaries from a single state during 1999-2001 with only 20% receiving beta-blockers may limit generalizability.</s></p><p><s>In conclusion, Medicare beneficiaries who are hospitalized from the LTC for decompensated HF, there is no evidence of any association between digoxin use and 30-day or 1-year allcause or HF readmission.</s><s>These findings suggest that digoxin should not be routinely use for lowering the risk of 30-day all-cause readmission in these patients.</s><s>Future studies with larger sample size and more contemporary HF patients from the LTC setting are needed to determine the role of digoxin in hospitalized HF patients admitted from the LTC setting.</s><s>Love plot displaying absolute standardized differences for 29 baseline characteristics between patients receiving and not receiving digoxin, before and after propensity score matching are indicated by blank circle and black diamond shapes; ACE= Angiotensin converting enzyme Kaplan-Meier plots for the combined end point of 30-day all-cause hospital readmission or 30-day all-cause mortality in a propensity-matched cohort of older heart failure patients admitted from nursing homes receiving and not receiving a discharge prescription for digoxin (CI=confidence interval)</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc><div><p><s>Figure 1.</s></p></div></figDesc><graphic coords="8,188.40,62.00,295.20,361.92" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 2 .</head><label>2</label><figDesc><div><p><s>Figure 2.</s></p></div></figDesc><graphic coords="9,166.56,62.00,338.88,262.08" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1</head><label>1</label><figDesc><div><p><s>characteristics of nursing home residents hospitalized for decompensated heart failure, by discharge prescription for digoxin, before and after propensity score matching</s></p></div></figDesc><table><row><cell>n (%)</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>or mean (±SD) Pre-match (N=545) Post-match (N=316) Use of digoxin P value Use of digoxin P value No (n=318) Yes (n=227) No (n=158) Yes (n=158)</head><label></label><figDesc></figDesc><table><row><cell></cell><cell cols="3">Sheriff et al.</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Page 11</cell></row><row><cell></cell><cell>P value</cell><cell></cell><cell>0.585</cell><cell>0. 901</cell><cell>0.725</cell><cell>1.000</cell><cell></cell><cell>0.569</cell><cell>0.328</cell><cell>0.905</cell><cell>0.392</cell><cell></cell><cell>0.651</cell><cell>0.821</cell><cell>0.445</cell><cell></cell><cell>0.733</cell><cell>0.238</cell><cell>0.520</cell><cell>0.658</cell><cell></cell><cell>0.910</cell><cell>1.000</cell><cell>0.754</cell><cell>1.000</cell><cell>0.910</cell><cell></cell><cell></cell></row><row><cell>Post-match (N=316)</cell><cell>Use of digoxin</cell><cell>No (n=158) Yes (n=158)</cell><cell>141 (±30) 143 (±30)</cell><cell>75 (±20) 75 (±18)</cell><cell>100 (63) 103 (65)</cell><cell>132 (84) 132 (84)</cell><cell></cell><cell>139 (±5) 139 (±7)</cell><cell>4.5 (±0.8) 4.4 (±0.7)</cell><cell>1.4 (±0.7) 1.4 (±0.7)</cell><cell>35 (±6) 36 (±6)</cell><cell></cell><cell>72 (46%) 68 (43%)</cell><cell>11 (7%) 10 (6%)</cell><cell>45 (29%) 39 (25%)</cell><cell></cell><cell>70 (44%) 67 (42%)</cell><cell>60 (38%) 50 (32%)</cell><cell>4 (3%) 6 (4%)</cell><cell>7 (±6) 7 (±4)</cell><cell></cell><cell>80 (51%) 79 (50%)</cell><cell>30 (19%) 30 (19%)</cell><cell>133 (84%) 135 (85%)</cell><cell>17 (11%) 17 (11%)</cell><cell>75 (48%) 76 (48%)</cell><cell></cell><cell></cell></row><row><cell></cell><cell>P value</cell><cell></cell><cell>0.072</cell><cell>0.981</cell><cell>0.801</cell><cell>0.499</cell><cell></cell><cell>0.311</cell><cell>0.348</cell><cell>0.003</cell><cell>0.143</cell><cell></cell><cell>0.891</cell><cell>0.036</cell><cell>0.722</cell><cell></cell><cell>0.319</cell><cell>0.153</cell><cell>0.809</cell><cell>0.492</cell><cell></cell><cell>&lt;0.001</cell><cell>0.332</cell><cell>&lt;0.001</cell><cell>0.034</cell><cell>0.018</cell><cell></cell><cell></cell></row><row><cell>Pre-match (N=545)</cell><cell>Use of digoxin</cell><cell>No (n=318) Yes (n=227)</cell><cell>146 (±32) 142 (±30)</cell><cell>75 (±19) 75 (±19)</cell><cell>204 (64) 148 (66)</cell><cell>262 (82) 192 (85)</cell><cell>0.700</cell><cell>1.000 139 (±5) 138 (±7)</cell><cell>0.306 4.5 (±0.8) 4.4 (±0.7)</cell><cell>0.498 1.6 (±1.1) 1.3 (±0.7)</cell><cell>35 (±6) 36 (±6)</cell><cell></cell><cell>0.406 141 (44%) 102 (45%)</cell><cell>11 (4%) 17 (8%)</cell><cell>87 (27%) 59 (26%)</cell><cell>0.780</cell><cell>0.708 121 (38%) 96 (42%)</cell><cell>0.735 95 (30%) 81 (36%)</cell><cell>0.676 11 (4%) 7 (3%)</cell><cell>1.000 7 (±6) 7 (±5)</cell><cell>0.581</cell><cell>0.532 124 (39%) 126 (56%)</cell><cell>0.861 58 (18%) 49 (22%)</cell><cell>0.909 232 (73%) 198 (87%)</cell><cell>0.463 30 (9%) 35 (15%)</cell><cell>0.908 126 (40%) 113 (50%)</cell><cell>0.643</cell><cell>0.736</cell><cell>0.729</cell></row><row><cell></cell><cell>n (%) or mean (±SD)</cell><cell></cell><cell>Systolic blood pressure (mmHg)</cell><cell>Diastolic blood pressure (mmHg)</cell><cell>Lower extremity edema</cell><cell>Pulmonary edema by chest x-ray</cell><cell>0.061 83 (±8) 83 (±9) Laboratory values</cell><cell>0.516 117 (74%) 117 (74%) Serum sodium (mEq/L)</cell><cell>0.020 32 (20%) 25 (16%) Serum potassium (mEq/L)</cell><cell>0.945 12 (8%) 9 (6%) Serum creatinine (mEq/L)</cell><cell>Hematocrit (%)</cell><cell>44 (28%) 34 (22%) In-hospital events</cell><cell>&lt;0.001 39 (25%) 40 (25%) Pneumonia</cell><cell>75 (48%) 84 (53%) Acute myocardial infarction</cell><cell>Pressure ulcer</cell><cell>0.002 125 (79%) 127 (80%) Hospital and care characteristics</cell><cell>0.295 112 (71%) 115 (73%) Rural hospital</cell><cell>0.982 73 (46%) 76 (48%) Cardiology consult</cell><cell>0.958 34 (22%) 31 (20%) Intensive care unit</cell><cell>0.391 18 (11%) 18 (11%) Length of stay (days)</cell><cell>0.199 15 (10%) 18 (11%) Discharge medications</cell><cell>0.934 11 (7%) 14 (9%) ACE inhibitors or ARBs</cell><cell>0.892 18 (11%) 19 (12%) Beta-blockers</cell><cell>0.021 66 (42%) 67 (42%) Loop diuretics</cell><cell>&lt;0.001 51 (32%) 45 (29%) Potassium-sparing diuretics</cell><cell>0.762 63 (40%) 62 (39%) Potassium supplements</cell><cell>0.158 58 (37%) 62 (39%)</cell><cell>0.023 78 (49%) 75 (48%)</cell><cell>0.061 92 (±22) 93 (±24)</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>84 (±8)</cell><cell>165 (73%)</cell><cell>32 (14%)</cell><cell>11 (5%)</cell><cell></cell><cell>46 (20%)</cell><cell>71 (31%)</cell><cell>110 (49%)</cell><cell></cell><cell>188 (83%)</cell><cell>163 (72%)</cell><cell>104 (46%)</cell><cell>41 (18%)</cell><cell>25 (11%)</cell><cell>26 (12%)</cell><cell>16 (7%)</cell><cell>28 (12%)</cell><cell>86 (38%)</cell><cell>93 (41%)</cell><cell>90 (40%)</cell><cell>89 (39%)</cell><cell>118 (52%)</cell><cell>94 (±24)</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Age (years) 82 (±9)</cell><cell>Female 239 (75%)</cell><cell>African American 70 (22%)</cell><cell>Current smoker 15 (5%)</cell><cell>Left ventricular ejection fraction (%)</cell><cell>≥45% 103 (32%)</cell><cell>&lt;45% 51 (16%)</cell><cell>Unknown 164 (52%)</cell><cell>Past medical history</cell><cell>Prior heart failure 226 (71%)</cell><cell>Hypertension 215 (68%)</cell><cell>Coronary artery disease 146 (46%)</cell><cell>Myocardial infarction 58 (18%)</cell><cell>Angina pectoris 28 (9%)</cell><cell>Left bundle branch block 26 (8%)</cell><cell>Percutaneous coronary intervention 23 (7%)</cell><cell>Coronary artery bypass graft 38 (12%)</cell><cell>Diabetes mellitus 152 (48%)</cell><cell>Atrial fibrillation 62 (19%)</cell><cell>Stroke 122 (38%)</cell><cell>Chronic obstructive pulmonary disease 106 (33%)</cell><cell>Dementia 134 (42%)</cell><cell>Clinical findings</cell><cell>Pulse (beats per minute) 90 (±22)</cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">J Am Med Dir Assoc. Author manuscript; available in PMC 2018 September 01.</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p><s>Funding: Dr. Ahmed was in part supported by the National Institutes of Health (NIH) through grants (R01-HL085561, R01-HL085561-S and R01-HL097047) from the National Heart, Lung, and Blood Institute</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Author Manuscript</head><p><s>The hazard ratios compared patients receiving digoxin versus those not receiving digoxin.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<title level="m" type="main">Rehospitalizations among patients in the Medicare fee-forservice program. The New Englandjournal of medicine</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">F</forename><surname>Jencks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Coleman</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2009">2009</date>
			<biblScope unit="volume">360</biblScope>
			<biblScope unit="page" from="1418" to="1428" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<monogr>
		<title level="m" type="main">Hospitals Face Pressure to Avert Readmissions. The New York Times</title>
		<author>
			<persName><forename type="first">J</forename><surname>Rau</surname></persName>
		</author>
		<ptr target="http://www.nytimes.com/2012/11/27/health/hospitals-face-pressure-from-medicare-to-avert-readmissions.html?_r=0.Accessdate" />
		<imprint>
			<date type="published" when="2012-12-02">2012. December 2, 2012</date>
			<pubPlace>New York</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Digoxin use and lower 30-day all-cause readmission for Medicare beneficiaries hospitalized for heart failure</title>
		<author>
			<persName><forename type="first">A</forename><surname>Ahmed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Bourge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">C</forename><surname>Fonarow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Med</title>
		<imprint>
			<biblScope unit="volume">127</biblScope>
			<biblScope unit="page" from="61" to="70" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>PubMed: 24257326</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Digoxin Reduces 30-day All-cause Hospital Admission in Older Patients with Chronic Systolic Heart Failure</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Bourge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Fleg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">C</forename><surname>Fonarow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Med</title>
		<imprint>
			<biblScope unit="volume">126</biblScope>
			<biblScope unit="page" from="701" to="708" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23490060</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Elderly nursing home patients with congestive heart failure after myocardial infarction living in new york city have a higher prevalence of mortality in cold weather and warm weather months</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">S</forename><surname>Aronow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Ahn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Gerontol A Biol Sci Med Sci</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="146" to="147" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note>PubMed: 14999028</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Cardiovascular disease care in the nursing home: the need for better evidence for outcomes of care and better quality for processes of care</title>
		<author>
			<persName><forename type="first">A</forename><surname>Ahmed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">J</forename><surname>Ekundayo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Med Dir Assoc</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="1" to="3" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>PubMed: 19111846</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Baseline characteristics, quality of care, and outcomes of younger and older Medicare beneficiaries hospitalized with heart failure: findings from the Alabama Heart Failure Project</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Feller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mujib</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Cardiol</title>
		<imprint>
			<biblScope unit="volume">162</biblScope>
			<biblScope unit="page" from="39" to="44" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>PubMed: 21621285</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Renin-angiotensin inhibition in systolic heart failure and chronic kidney disease</title>
		<author>
			<persName><forename type="first">A</forename><surname>Ahmed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">C</forename><surname>Fonarow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Med</title>
		<imprint>
			<biblScope unit="volume">125</biblScope>
			<biblScope unit="page" from="399" to="410" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>PubMed: 22321760</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Renin-angiotensin inhibition in diastolic heart failure and chronic kidney disease</title>
		<author>
			<persName><forename type="first">A</forename><surname>Ahmed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Rich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zile</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Med</title>
		<imprint>
			<biblScope unit="volume">126</biblScope>
			<biblScope unit="page" from="150" to="161" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23331442</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">The central role of propensity score in observational studies for causal effects</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">R</forename><surname>Rosenbaum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Rubin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biometrika</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="page" from="41" to="55" />
			<date type="published" when="1983">1983</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Using propensity score to help design observational studies: Application to the tobacco litigation</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Rubin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Health Services and Outcomes Research Methodology</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="169" to="188" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods</title>
		<author>
			<persName><forename type="first">A</forename><surname>Ahmed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Husain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Love</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="1431" to="1439" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note>PubMed: 16709595</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial</title>
		<author>
			<persName><forename type="first">A</forename><surname>Ahmed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Rich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Love</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="178" to="186" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note>PubMed: 16339157</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Primer on statistical interpretation or methods report card on propensity-score matching in the cardiology literature from 2004 to 2006: a systematic review</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Austin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circ Cardiovasc Qual Outcomes</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="62" to="67" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>PubMed: 20031790</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Angiotensin-converting Enzyme Inhibitors and Outcomes in Heart Failure and Preserved Ejection Fraction</title>
		<author>
			<persName><forename type="first">M</forename><surname>Mujib</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">C</forename><surname>Fonarow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Med</title>
		<imprint>
			<biblScope unit="volume">126</biblScope>
			<biblScope unit="page" from="401" to="410" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23510948</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">A propensity-matched study of outcomes of chronic heart failure (HF) in younger and older adults</title>
		<author>
			<persName><forename type="first">C</forename><surname>Wahle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Adamopoulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">J</forename><surname>Ekundayo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mujib</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">S</forename><surname>Aronow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ahmed</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Gerontol Geriatr</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="page" from="165" to="171" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>PubMed: 18692914</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Sensitivity to hidden bias</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">R</forename><surname>Rosenbaum</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Observational Studies</title>
		<editor>Rosenbaum, PR.</editor>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="105" to="170" />
			<date type="published" when="2002">2002</date>
			<publisher>Springer-Verlag</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial</title>
		<author>
			<persName><forename type="first">A</forename><surname>Ahmed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Rich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Fleg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">114</biblScope>
			<biblScope unit="page" from="397" to="403" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note>PubMed: 16864724</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial</title>
		<author>
			<persName><forename type="first">M</forename><surname>Gheorghiade</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Filippatos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Heart Fail</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="551" to="559" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23355060</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial: a retrospective analysis</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">F</forename><surname>Adams</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Patterson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">A</forename><surname>Gattis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="497" to="504" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note>PubMed: 16053964</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Serum digoxin concentration and outcomes in women with heart failure: A bi-directional effect and a possible effect modification by ejection fraction</title>
		<author>
			<persName><forename type="first">A</forename><surname>Ahmed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">B</forename><surname>Aban</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Weaver</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">S</forename><surname>Aronow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Fleg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur JHeart Fail</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="409" to="419" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note>PubMed: 16311070</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Sex-based differences in the effect of digoxin for the treatment of heart failure</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Rathore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Krumholz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">347</biblScope>
			<biblScope unit="page" from="1403" to="1411" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note>PubMed: 12409542</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. population-based cohort of men with prostate cancer</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Daskivich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Fan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Koyama</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Intern Med</title>
		<imprint>
			<biblScope unit="volume">158</biblScope>
			<biblScope unit="page" from="709" to="717" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23689764</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Comorbidity and competing risks for mortality in men with prostate cancer</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Daskivich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Chamie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Kwan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer</title>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="page" from="4642" to="4650" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>PubMed: 21480201</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Chronic-Conditions/Downloads/ 2011Chartbook.pdf Access date</title>
		<ptr target="http://www.cms.gov/" />
	</analytic>
	<monogr>
		<title level="m">The Centers for Medicare &amp; Medicaid Services. Chronic Conditions among Medicare Beneficiaries</title>
				<meeting><address><addrLine>Baltimore, MD</addrLine></address></meeting>
		<imprint>
			<date type="published" when="2012-08-28">August 28. 2012</date>
		</imprint>
	</monogr>
	<note>Chart Book</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Appropriate use of digoxin in treating older nursing home patients with heart failure</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">S</forename><surname>Aronow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Med Dir Assoc</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="604" to="606" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note>PubMed: 17095428</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Digoxin prescribing for heart failure in elderly residents of long-term care facilities</title>
		<author>
			<persName><forename type="first">B</forename><surname>Misiaszek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Heckman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Merali</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Can J Cardiol</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="281" to="286" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note>PubMed: 15776118</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies</title>
		<author>
			<persName><forename type="first">R</forename><surname>Clarke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Shipley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lewington</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Epidemiol</title>
		<imprint>
			<biblScope unit="volume">150</biblScope>
			<biblScope unit="page" from="341" to="353" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
	<note>PubMed: 10453810</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
